<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Enrollment characteristic of women who had undergone cervical surgery after randomization to HPV-16/18 AS04-adjuvanted vaccine or placebo. * The total percentages of each HPV type is not necessarily equal to 100% because a result may be counted more than once in cases where the participants contained multiple HPV type. ASCUS: atypical squamous cells of undetermined significance; ASCH: atypical squamous cell, but cannot exclude high-grade squamous intraepithelial lesion; AGC: atypical glandular cells; LSIL: low-grade squamous intraepithelial lesion; HSIL: high-grade squamous intraepithelial lesion; Inadequate: unsatisfactory cytological results; HPV: human papillomavirus; HR-HPV: high-risk human papillomavirus; LR-HPV: low-risk human papillomavirus</p>
 </caption>
 <graphic position="anchor" xlink:href="12879_2020_5560_Tab1_HTML" id="MO3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</table-wrap>
